HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.
HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $58 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $58 price target.
Block Analyst Ups Price Target For Stock Ahead Of Q4 Results: ‘We Are Positive, Headed Into The Print…’
Jack Dorsey-led Block Inc. (NYSE: SQ) is scheduled to release its fourth-quarter results on Thursday after the market close.
HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $3 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Cowen & Co. Reiterates Market Perform on Jack In The Box, Maintains $80 Price Target
Cowen & Co. analyst Andrew Charles reiterates Jack In The Box (NASDAQ:JACK) with a Market Perform and maintains $80 price target.
Needham Reiterates Buy on AtriCure, Maintains $58 Price Target
Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $58 price target.
Telsey Advisory Group Reiterates Market Perform on American Eagle Outfitters, Maintains $17 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates American Eagle Outfitters (NYSE:AEO) with a Market Perform and maintains $17 price target.
DA Davidson Reiterates Buy on Coty, Maintains $13 Price Target
DA Davidson analyst Linda Bolton Weiser reiterates Coty (NYSE:COTY) with a Buy and maintains $13 price target.
Needham Reiterates Buy on Esperion Therapeutics, Maintains $12 Price Target
Needham analyst Serge Belanger reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $12 price target.
Hyatt Has Positive Transformations Rolling-On, Says Analyst
Truist Securities analyst Patrick Scholes reiterated a Buy rating on the shares of Hyatt Hotels Corporation (NYSE:H) and raised the price target…